Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Sandborn

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Mayo Clinic Proceedings|January 1, 1996
Methotrexate for inflammatory bowel disease: pharmacology and preliminary resultsL J Egan, W J Sandborn
Mayo Clinic Proceedings|October 1, 1992
Cyclosporine treatment of inflammatory bowel diseaseW J Sandborn, W J Tremaine
Alimentary Pharmacology & Therapeutics|May 15, 2004
Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteersW J Sandborn, S B Hanauer, A Buch
Alimentary Pharmacology & Therapeutics|February 22, 2002
The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic reviewE V Loftus, P Schoenfeld, W J Sandborn
Alimentary Pharmacology & Therapeutics|January 16, 2007
Review article: biological activity markers in inflammatory bowel diseaseD Desai, W A Faubion, W J Sandborn
Inflammatory Bowel Diseases|February 24, 1999
Medical therapy for induction and maintenance of remission in pouchitis: a systematic reviewW J Sandborn, R McLeod, D P Jewell
The American Journal of Gastroenterology|September 1, 1995
Collagenous and lymphocytic colitis: subject review and therapeutic alternativesB J Zins, W J Sandborn, W J Tremaine
The American Journal of Gastroenterology|January 1, 1996
Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporineW J Sandborn, W J Tremaine, G M Lawson
Alimentary Pharmacology & Therapeutics|February 16, 2005
Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trialS Hanauer, W J Sandborn, A Persson, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remissionW J Sandborn, B G Feagan, G R Lichtenstein
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Mayo Clinic Proceedings|January 1, 1996
Methotrexate for inflammatory bowel disease: pharmacology and preliminary resultsL J Egan, W J Sandborn
Mayo Clinic Proceedings|October 1, 1992
Cyclosporine treatment of inflammatory bowel diseaseW J Sandborn, W J Tremaine
Alimentary Pharmacology & Therapeutics|May 15, 2004
Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteersW J Sandborn, S B Hanauer, A Buch
Alimentary Pharmacology & Therapeutics|February 22, 2002
The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic reviewE V Loftus, P Schoenfeld, W J Sandborn
Alimentary Pharmacology & Therapeutics|January 16, 2007
Review article: biological activity markers in inflammatory bowel diseaseD Desai, W A Faubion, W J Sandborn
Inflammatory Bowel Diseases|February 24, 1999
Medical therapy for induction and maintenance of remission in pouchitis: a systematic reviewW J Sandborn, R McLeod, D P Jewell
The American Journal of Gastroenterology|September 1, 1995
Collagenous and lymphocytic colitis: subject review and therapeutic alternativesB J Zins, W J Sandborn, W J Tremaine
The American Journal of Gastroenterology|January 1, 1996
Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporineW J Sandborn, W J Tremaine, G M Lawson
Alimentary Pharmacology & Therapeutics|February 16, 2005
Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trialS Hanauer, W J Sandborn, A Persson, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remissionW J Sandborn, B G Feagan, G R Lichtenstein
Pageof 19